These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 33882283)
1. Evaluation of the diagnostic performance of an oral fluid screening test device for substance abuse at traffic controls. Avcioglu G; Yilmaz G; Yalcin Sahiner S; Kozaci LD; Bal C; Yilmaz FM Clin Biochem; 2021 Jul; 93():112-118. PubMed ID: 33882283 [TBL] [Abstract][Full Text] [Related]
2. Roche DAT immunoassay: sensitivity and specificity testing for amphetamines, cocaine, and opiates in oral fluid. Crooks CR; Brown S J Anal Toxicol; 2010 Mar; 34(2):103-9. PubMed ID: 20223103 [TBL] [Abstract][Full Text] [Related]
3. Trends in drivers testing positive for drugs of abuse in oral fluid from 2018 to 2021 in France. Willeman T; Bartolli M; Jourdil JF; Vial S; Eysseric-Guérin H; Stanke-Labesque F Forensic Sci Int; 2023 Nov; 352():111835. PubMed ID: 37748427 [TBL] [Abstract][Full Text] [Related]
4. Confirmation by LC-MS of drugs in oral fluid obtained from roadside testing. Concheiro M; de Castro A; Quintela O; Cruz A; López-Rivadulla M Forensic Sci Int; 2007 Aug; 170(2-3):156-62. PubMed ID: 17658709 [TBL] [Abstract][Full Text] [Related]
5. Detection of Delta9-tetrahydrocannabinol and amphetamine-type stimulants in oral fluid using the Rapid Stat point-of-collection drug-testing device. Röhrich J; Zörntlein S; Becker J; Urban R J Anal Toxicol; 2010 Apr; 34(3):155-61. PubMed ID: 20406540 [TBL] [Abstract][Full Text] [Related]
6. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood. Pehrsson A; Gunnar T; Engblom C; Seppä H; Jama A; Lillsunde P Forensic Sci Int; 2008 Mar; 175(2-3):140-8. PubMed ID: 17640837 [TBL] [Abstract][Full Text] [Related]
7. Detection of illicit drugs in oral fluid from drivers as biomarker for drugs in blood. Gjerde H; Langel K; Favretto D; Verstraete AG Forensic Sci Int; 2015 Nov; 256():42-5. PubMed ID: 26295911 [TBL] [Abstract][Full Text] [Related]
8. Performance evaluation of the DrugWipe® 5/5+ on-site oral fluid screening device. Pehrsson A; Blencowe T; Vimpari K; Impinen A; Gunnar T; Lillsunde P Int J Legal Med; 2011 Sep; 125(5):675-83. PubMed ID: 20652713 [TBL] [Abstract][Full Text] [Related]
9. Analytical evaluation of four on-site oral fluid drug testing devices. Vanstechelman S; Isalberti C; Van der Linden T; Pil K; Legrand SA; Verstraete AG J Anal Toxicol; 2012 Mar; 36(2):136-40. PubMed ID: 22337784 [TBL] [Abstract][Full Text] [Related]
10. Development and validation of a single LC-MS/MS assay following SPE for simultaneous hair analysis of amphetamines, opiates, cocaine and metabolites. Imbert L; Dulaurent S; Mercerolle M; Morichon J; Lachâtre G; Gaulier JM Forensic Sci Int; 2014 Jan; 234():132-8. PubMed ID: 24378313 [TBL] [Abstract][Full Text] [Related]
11. Identification and quantitation of amphetamines, cocaine, opiates, and phencyclidine in oral fluid by liquid chromatography-tandem mass spectrometry. Fritch D; Blum K; Nonnemacher S; Haggerty BJ; Sullivan MP; Cone EJ J Anal Toxicol; 2009; 33(9):569-77. PubMed ID: 20040131 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the IDS One-Step ELISA kits for the detection of illicit drugs in hair. Pujol ML; Cirimele V; Tritsch PJ; Villain M; Kintz P Forensic Sci Int; 2007 Aug; 170(2-3):189-92. PubMed ID: 17628371 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of on-site oral fluid screening using Drugwipe-5(+), RapidSTAT and Drug Test 5000 for the detection of drugs of abuse in drivers. Wille SM; Samyn N; Ramírez-Fernández Mdel M; De Boeck G Forensic Sci Int; 2010 May; 198(1-3):2-6. PubMed ID: 19913376 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of three rapid oral fluid test devices on the screening of multiple drugs of abuse including ketamine. Tang MHY; Ching CK; Poon S; Chan SSS; Ng WY; Lam M; Wong CK; Pao R; Lau A; Mak TWL Forensic Sci Int; 2018 May; 286():113-120. PubMed ID: 29574346 [TBL] [Abstract][Full Text] [Related]
15. Field Detection of Drugs of Abuse in Oral Fluid Using the Alere™ DDS®2 Mobile Test System with Confirmation by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS). Krotulski AJ; Mohr ALA; Friscia M; Logan BK J Anal Toxicol; 2018 Apr; 42(3):170-176. PubMed ID: 29301050 [TBL] [Abstract][Full Text] [Related]
16. Simultaneous screening and quantification of 29 drugs of abuse in oral fluid by solid-phase extraction and ultraperformance LC-MS/MS. Badawi N; Simonsen KW; Steentoft A; Bernhoft IM; Linnet K Clin Chem; 2009 Nov; 55(11):2004-18. PubMed ID: 19797719 [TBL] [Abstract][Full Text] [Related]
17. Oral Fluid and Drug Impairment: Pairing Toxicology with Drug Recognition Expert Observations. Truver MT; Palmquist KB; Swortwood MJ J Anal Toxicol; 2019 Sep; 43(8):637-643. PubMed ID: 31504595 [TBL] [Abstract][Full Text] [Related]
18. On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users. Samyn N; van Haeren C Int J Legal Med; 2000; 113(3):150-4. PubMed ID: 10876986 [TBL] [Abstract][Full Text] [Related]
19. A new ultraperformance-tandem mass spectrometry oral fluid assay for 29 illicit drugs and medications. Huestis MA Clin Chem; 2009 Dec; 55(12):2079-81. PubMed ID: 19833833 [No Abstract] [Full Text] [Related]
20. Optimization and validation of CEDIA drugs of abuse immunoassay tests in serum on Hitachi 912. Kirschbaum KM; Musshoff F; Schmithausen R; Stockhausen S; Madea B Forensic Sci Int; 2011 Oct; 212(1-3):252-5. PubMed ID: 21775079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]